Published 21 hours ago • loading... • Updated 21 hours ago

QIAGEN and Incyte Join Forces on Revolutionary Diagnostic Panel for Rare Blood Cancers

Summary by stocktitan.net

New NGS diagnostic panel targets rare blood cancers, enabling precise treatment selection for MPN patients. Partnership expands QIAGEN's oncology diagnostic portfolio. Learn more.

4 Articles

All

Left

Center

Right

Hastings Tribune

+2 Reposted by 2 other sources

Center

QIAGEN and Incyte Announce Precision Medicine Collaboration to Develop Companion Diagnostics for Patients With Mutant CALR-expressing Myeloproliferative Neoplasms (MPNs)

VENLO, Netherlands & WILMINGTON, Del.--(BUSINESS WIRE)--Jun 15, 2025-

21 hours ago

Read Full Article

stocktitan.net

QIAGEN and Incyte Join Forces on Revolutionary Diagnostic Panel for Rare Blood Cancers

New NGS diagnostic panel targets rare blood cancers, enabling precise treatment selection for MPN patients. Partnership expands QIAGEN's oncology diagnostic portfolio. Learn more.

21 hours ago

Read Full Article

Think freely.Subscribe and get full access to Ground NewsSubscriptions start at $9.99/year